Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig are simulating the effect of various conditions on the development of the SARS-CoV-2 epidemic in Germany. Their results suggest that the...
An interdisciplinary group of renowned scientists - among them Prof Gérard Krause, head of the Department Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig - is now calling for the...
The Covid-19 pandemic affects more and more countries worldwide. Since the virus causes no or only mild symptoms in many infected people, researchers assume that the number of unreported cases is high. In order to slow...
After an infection with the coronavirus SARS-CoV-2, patients have antibodies against the pathogen in their blood. These are retained over a long period of time and are an indication for a past infection. It is assumed...
The new coronavirus SARS-CoV-2 has been identified as the pathogen behind the COVID-19 pandemic. The virus contains a main protease termed Mpro (or also termed 3CLpro), which is involved in the development of the virus’...
Weltweit infizieren sich immer mehr Menschen mit dem neuartigen Coronavirus, betroffen sind mehr als 140 Länder (Stand 15.03.2020). Deshalb hat die Weltgesundheitsorganisation WHO inzwischen die Situation zur Pandemie...
The human immune system can recognize and eliminate not only germs but also cancer cells. This is why treatments with weakened germs can help the immune system in its fight against cancer. Researchers at the Max Planck...
More than three percent of the world's population (about 260 million humans) are chronically infected with the hepatitis B virus (HBV). Worldwide 880,000 humans die each year from the sequelae: liver cirrhosis and...
